By Morgan Eichensehr – Reporter, Baltimore Business Journal
Jan 17 2019
via BIZ JOURNALS
Hopkins, Emocha win CDC funding to study effect of financial incentives on addiction recovery
The U.S. Centers for Disease Control and Prevention (CDC) is putting $2.1 million behind a study to be conducted by Johns Hopkins researchers, using technology developed by a local startup.
The study is designed to see if financial incentives improve the likelihood that patients recovering from opioid use disorder stick to their medication plans. Emocha Mobile Health, a Baltimore health tech firm with ties to Hopkins, has developed a platform designed to increase this so-called "medication adherence" among patients with certain diseases or conditions that require strict or specific drug regimes. Emocha's tech will be used in this study, which will focus on patients using buprenorphine for medication-assisted addiction recovery treatments.